IL312919B1 - Peptide assay to distinguish between full-length high molecular weight kinogen (HMWK) and cleaved HMWK - Google Patents
Peptide assay to distinguish between full-length high molecular weight kinogen (HMWK) and cleaved HMWKInfo
- Publication number
- IL312919B1 IL312919B1 IL312919A IL31291924A IL312919B1 IL 312919 B1 IL312919 B1 IL 312919B1 IL 312919 A IL312919 A IL 312919A IL 31291924 A IL31291924 A IL 31291924A IL 312919 B1 IL312919 B1 IL 312919B1
- Authority
- IL
- Israel
- Prior art keywords
- hmwk
- peptide
- seq
- sample
- digested
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/224—Haemostasis or coagulation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562267734P | 2015-12-15 | 2015-12-15 | |
| PCT/US2016/066936 WO2017106504A1 (en) | 2015-12-15 | 2016-12-15 | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL312919A IL312919A (en) | 2024-07-01 |
| IL312919B1 true IL312919B1 (en) | 2025-10-01 |
Family
ID=57794352
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL312919A IL312919B1 (en) | 2015-12-15 | 2016-12-15 | Peptide assay to distinguish between full-length high molecular weight kinogen (HMWK) and cleaved HMWK |
| IL322971A IL322971A (en) | 2015-12-15 | 2016-12-15 | Method for evaluating the efficacy of a drug for a plasma kallikrein-mediated disorder |
| IL297850A IL297850B2 (en) | 2015-12-15 | 2016-12-15 | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK |
| IL259995A IL259995B2 (en) | 2015-12-15 | 2018-06-13 | A test to determine the amount of peptide in order to distinguish between full-length high molecular weight kinogen (hmwk) and cleaved hmwk |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL322971A IL322971A (en) | 2015-12-15 | 2016-12-15 | Method for evaluating the efficacy of a drug for a plasma kallikrein-mediated disorder |
| IL297850A IL297850B2 (en) | 2015-12-15 | 2016-12-15 | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK |
| IL259995A IL259995B2 (en) | 2015-12-15 | 2018-06-13 | A test to determine the amount of peptide in order to distinguish between full-length high molecular weight kinogen (hmwk) and cleaved hmwk |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11668718B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4597115A3 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7092669B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR102874711B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN108602877A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2016372159B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3008621A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2018007216A2 (cg-RX-API-DMAC7.html) |
| EA (1) | EA201891414A1 (cg-RX-API-DMAC7.html) |
| IL (4) | IL312919B1 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2018007493A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ743482A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017106504A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3060582B1 (en) | 2013-10-21 | 2020-09-23 | Dyax Corp. | Assays for determining plasma kallikrein system biomarkers |
| US10101344B2 (en) | 2013-10-21 | 2018-10-16 | Dyax Corp. | Diagnosis and treatment of autoimmune diseases |
| DK3365685T3 (da) | 2015-10-19 | 2021-03-01 | Dyax Corp | Immunoassay til påvisning af spaltet højmolekylært kininogen |
| EP4597115A3 (en) | 2015-12-15 | 2025-08-13 | Takeda Pharmaceutical Company Limited | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk |
| EP3637106B1 (en) * | 2017-06-08 | 2023-03-22 | University of Miyazaki | Lung cancer detection method |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2216651A1 (en) * | 2007-10-18 | 2010-08-11 | Miyazaki Prefectural Industrial Support Foundation | Biomarker for diagnosis of liver disease |
| WO2014113712A1 (en) * | 2013-01-20 | 2014-07-24 | Dyax Corp. | Evaluation and treatment of bradykinin-mediated disorders |
| WO2016081413A1 (en) * | 2014-11-17 | 2016-05-26 | The Rockefeller University | Compositions and methods for use in diagnosis of alzheimer's disease |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047323A (en) * | 1986-01-22 | 1991-09-10 | Temple University Of The Commonwealth System Of Higher Education | Method for detecting human kininogen using monoclonal antibodies thereto |
| JP2603487B2 (ja) | 1987-11-26 | 1997-04-23 | 大日本製薬株式会社 | ガンに罹患している疑いのあるヒトをスクリーニングする方法 |
| JPH08208692A (ja) | 1994-09-28 | 1996-08-13 | Sumitomo Pharmaceut Co Ltd | 新規な細胞接着抑制ペプチド誘導体 |
| JP3073439B2 (ja) * | 1996-02-08 | 2000-08-07 | 雪印乳業株式会社 | 骨形成促進及び骨吸収防止剤 |
| WO2000027415A2 (en) | 1998-11-10 | 2000-05-18 | Temple University - Of The Commonwealth System Of Higher Education | Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5 |
| US20060154319A1 (en) | 1999-04-29 | 2006-07-13 | Flodgaard Hans J | Inhibition of bradykinin release |
| AU1761601A (en) | 1999-11-12 | 2001-06-06 | Bristol-Myers Squibb Pharma Company | Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain |
| JP2006501139A (ja) | 2002-03-15 | 2006-01-12 | アテニュオン， エルエルシー | 血管形成阻害の標的としての細胞表面トロポミオシン |
| CN1858243A (zh) | 2005-04-30 | 2006-11-08 | 安徽省生物医学研究所 | 一种预测血管紧张素ii受体拮抗剂类降压药药物作用的方法及其应用 |
| US20110160434A1 (en) | 2008-07-07 | 2011-06-30 | Nippon Zoki Pharmaceutical Co., Ltd. | Fibromyalgia test method |
| GB0821721D0 (en) | 2008-11-27 | 2008-12-31 | Hansa Medical Ab | Antimicrobial therapy |
| DK3173792T3 (da) | 2009-03-30 | 2019-08-05 | Novartis Ag | Crp neo-epitop fibrose-assay |
| JP5714285B2 (ja) | 2010-09-29 | 2015-05-07 | 株式会社プロトセラ | 妊娠高血圧症候群マーカーおよびそれを用いた診断 |
| CN102558329A (zh) | 2010-12-10 | 2012-07-11 | 中国人民解放军军事医学科学院生物医学分析中心 | 一组特异性多肽及其在制备肺癌早期诊断试剂中的用途 |
| PL2831113T3 (pl) | 2012-03-28 | 2018-08-31 | Sanofi | Przeciwciała przeciwko ligandom receptora bradykininy B1 |
| JP2016188761A (ja) | 2013-08-23 | 2016-11-04 | 国立研究開発法人国立国際医療研究センター | 糖尿病腎症の発症または発症リスクの検出方法及びキット |
| EP3060582B1 (en) * | 2013-10-21 | 2020-09-23 | Dyax Corp. | Assays for determining plasma kallikrein system biomarkers |
| US10281473B2 (en) * | 2014-02-04 | 2019-05-07 | University Of Virginia Patent Foundation | Compositions and methods for analysis of protein sequences and post-translational modifications |
| CN104345154B (zh) | 2014-08-22 | 2016-10-26 | 北京蛋白质组研究中心 | 一种检测多肿瘤相关“多肽-蛋白组合式标志物”的双抗体夹心试剂盒 |
| CN104155457B (zh) | 2014-08-22 | 2016-11-16 | 北京蛋白质组研究中心 | 一种结直肠癌相关“多肽-蛋白组合式标志物”检测试剂盒 |
| EP4597115A3 (en) | 2015-12-15 | 2025-08-13 | Takeda Pharmaceutical Company Limited | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk |
-
2016
- 2016-12-15 EP EP25162494.6A patent/EP4597115A3/en active Pending
- 2016-12-15 NZ NZ743482A patent/NZ743482A/en unknown
- 2016-12-15 AU AU2016372159A patent/AU2016372159B2/en active Active
- 2016-12-15 IL IL312919A patent/IL312919B1/en unknown
- 2016-12-15 WO PCT/US2016/066936 patent/WO2017106504A1/en not_active Ceased
- 2016-12-15 CN CN201680079865.9A patent/CN108602877A/zh active Pending
- 2016-12-15 US US16/062,734 patent/US11668718B2/en active Active
- 2016-12-15 IL IL322971A patent/IL322971A/en unknown
- 2016-12-15 EA EA201891414A patent/EA201891414A1/ru unknown
- 2016-12-15 EP EP16825947.1A patent/EP3390439B1/en active Active
- 2016-12-15 JP JP2018531159A patent/JP7092669B2/ja active Active
- 2016-12-15 KR KR1020247036874A patent/KR102874711B1/ko active Active
- 2016-12-15 KR KR1020187020049A patent/KR102728491B1/ko active Active
- 2016-12-15 CO CONC2018/0007216A patent/CO2018007216A2/es unknown
- 2016-12-15 IL IL297850A patent/IL297850B2/en unknown
- 2016-12-15 MX MX2018007493A patent/MX2018007493A/es unknown
- 2016-12-15 CA CA3008621A patent/CA3008621A1/en active Pending
-
2018
- 2018-06-13 IL IL259995A patent/IL259995B2/en unknown
- 2018-06-15 MX MX2023000773A patent/MX2023000773A/es unknown
-
2022
- 2022-06-10 AU AU2022204058A patent/AU2022204058B2/en active Active
- 2022-06-16 JP JP2022096962A patent/JP7425117B2/ja active Active
-
2023
- 2023-04-28 US US18/308,813 patent/US12135329B2/en active Active
-
2024
- 2024-01-18 JP JP2024005910A patent/JP7758766B2/ja active Active
- 2024-09-24 US US18/894,192 patent/US20250172567A1/en active Pending
-
2025
- 2025-01-22 AU AU2025200412A patent/AU2025200412A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2216651A1 (en) * | 2007-10-18 | 2010-08-11 | Miyazaki Prefectural Industrial Support Foundation | Biomarker for diagnosis of liver disease |
| WO2014113712A1 (en) * | 2013-01-20 | 2014-07-24 | Dyax Corp. | Evaluation and treatment of bradykinin-mediated disorders |
| WO2016081413A1 (en) * | 2014-11-17 | 2016-05-26 | The Rockefeller University | Compositions and methods for use in diagnosis of alzheimer's disease |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL312919B1 (en) | Peptide assay to distinguish between full-length high molecular weight kinogen (HMWK) and cleaved HMWK | |
| Schaub et al. | Proteomic-based identification of cleaved urinary β2-microglobulin as a potential marker for acute tubular injury in renal allografts | |
| US8227251B2 (en) | Mass spectrum-based identification and quantitation of proteins and peptides | |
| US10175242B2 (en) | Personalized myeloma detection | |
| US20180372754A1 (en) | Bladder cancer biomarker proteins | |
| WO2010021822A3 (en) | Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites | |
| WO2006029369A3 (en) | Methods and compositions for measuring natriuretic peptides and uses thereof | |
| US20150111238A1 (en) | Method for detecting disease biomarkers | |
| JP2022141640A5 (cg-RX-API-DMAC7.html) | ||
| JP2019505185A5 (cg-RX-API-DMAC7.html) | ||
| Zhang et al. | Evaluation of sample preparation methods for label-free quantitative profiling of salivary proteome | |
| HK1214863A1 (zh) | 蛋白酶在中性粒細胞胞外誘捕網中的底物性質 | |
| Xia et al. | Label-free quantitative proteomic analysis of right ventricular remodeling in infant Tetralogy of Fallot patients | |
| ES2755928T3 (es) | Procedimiento de medición de productos de degradación peptídica de una cascada proteolítica en muestras de sangre | |
| Kuruppu et al. | Soluble and catalytically active endothelin converting enzyme-1 is present in cerebrospinal fluid of subarachnoid hemorrhage patients | |
| Dubois et al. | Dipeptidyl peptidase 9 (DPP9) from bovine testes: Identification and characterization as the short form by mass spectrometry | |
| NZ783522B2 (en) | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK | |
| NZ783522A (en) | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK | |
| WO2008005940A3 (en) | Isolation of analytes | |
| DK2013623T3 (da) | Fremgangsmåde til bestemmelse af forholdet mellem to forskellige peptider eller polynukleinsyrer | |
| Sabbagh et al. | Functional protease profiling for laboratory based diagnosis of invasive aspergillosis | |
| WO2009120962A3 (en) | Protein isoforms for diagnosis | |
| Pesek et al. | Native chromatographic sample preparation of serum, plasma and cerebrospinal fluid does not comprise a risk for proteolytic biomarker loss | |
| WO2011089453A4 (en) | Mass spectrometry-based protein identification | |
| WO2010024704A3 (en) | A gammacarboxyglutamate-rich protein, methods and assays for its detection, purification and quantification and uses thereof |